The Stocks Wall Street Is Watching
The following stocks may be
impacted due to significant news as noted:
Networking company Cisco
Systems
(
CSCO |
Quote |
Chart |
News |
PowerRating) has had its earnings estimates cut by UBS Warburg due to
a weaker than expected U.S. market. The firm maintains its "hold" rating with a
price target of $14.50.
Drug stocks are in the news
today as Abbott Labs
(
ABT |
Quote |
Chart |
News |
PowerRating) has received FDA approval for its
rheumatoid arthritis drug Humira. Keep an eye on Amgen
(
AMGN |
Quote |
Chart |
News |
PowerRating) as it
may sell-off due to new competition.
Merck
(
MRK |
Quote |
Chart |
News |
PowerRating) has
received FDA approval for its hay fever drug Singulair.
Bristol Myers
(
BMY |
Quote |
Chart |
News |
PowerRating)
is being reported by the New York Times as an ideal candidate for a takeover.
Conglomerate General
Electric
(
GE |
Quote |
Chart |
News |
PowerRating) will be facing its first strike in 30 years, which will
hinder production in U.S. plants. Workers are reacting to a $200 increase in
payments towards the company’s managed healthcare plan.
Pre-market action:
(
ENMD |
Quote |
Chart |
News |
PowerRating) +44%,
(
ERICY |
Quote |
Chart |
News |
PowerRating)
+8.5%,
(
AEOS |
Quote |
Chart |
News |
PowerRating) +5%,
(
CHKP |
Quote |
Chart |
News |
PowerRating) +4%,
(
AMAT |
Quote |
Chart |
News |
PowerRating) +2.5%,
(
ABT |
Quote |
Chart |
News |
PowerRating) +1.8%,
(
AMGN |
Quote |
Chart |
News |
PowerRating)
+0.8%,
(
CSCO |
Quote |
Chart |
News |
PowerRating) +0.15%.
(
PMTC |
Quote |
Chart |
News |
PowerRating) -25%,
(
RSTO |
Quote |
Chart |
News |
PowerRating)
-11%.